In light of the COVID-19 pandemic, we wish to inform you that we remain open for business and are progressing the work for our clients according to plan. At the same time, we are taking necessary precautions to protect the health of our employees, clients, and the members of our community. As part of our business continuity plans, we have put measures and precautions in place to ensure the safety of our employees and clients, while continuing to operate according to our high standards. Cellectricon is closely monitoring the situation and is taking proactive steps to maintain and protect our business and supply chain.
These changes include, but are not limited to:
- Following the guidelines and regulations issued by Swedish authorities on how to reduce risk to our employees and adopting proactive policies such as suspending all travel, restricting visitors, and providing flexible work schedules to facilitate different working patterns.
- Strategically ordering and stocking larger quantities of critical materials and reagents to secure sustained operation. For non-stockable materials and reagents, alternative suppliers have been procured wherever possible.
With these changes, Cellectricon is able to sustain business operations while keeping employees and clients safe. We are not currently experiencing any issues, and laboratories are operating at normal capacity. We will continue to monitor the situation, follow guidelines from official authorities, and take appropriate steps to protect our operations.
If you are experiencing disruptions in your research and would like to discuss possible ways for Cellectricon to support your work, you are very welcome to reach out to us here. Cellectricon’s team of neurobiologists, stem cell researchers and engineers remains dedicated to support our current and new clients and would be happy to discuss ways to support your chronic pain and neurodegeneration projects through our in vitro drug discovery services. Let us help you to accelerate your research!
We hope you stay safe and healthy during this time.
/The Cellectricon team